Posted AT 3:41 AM EDT on 22/09/05
Panel rejects U.S.-style registry for acne drug
There is no need for Canada to follow the U.S. lead and create a registry of patients taking an anti-acne drug that causes severe birth defects, an expert advisory panel has told Health Canada.
In its question-and-answer report posted on Health Canada's website this week, the 10-member panel said it "unanimously rejected" the notion of a U.S.
The full text of this article has 652 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
Breakdown 
- Our mental health crisis
- Globe series tackles stigma, tells stories of Canadians
Child's View
- Focus on malaria
- Scenes from life in Liberia
Earlier discussion
slideshow
- Medical marijuna
- Alison Myrden's painful battle with MS
Features
- Confronting cancer
- Globe Series concludes with look at people who blaze trails
- Battling cancer
- Breast cancer death rates declining
-
Special report:
A day in the life
5In pictures
- Best position in bed
- How you sleep can make you feel better or worse
